Paper22876972
Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury.
Chang CP and 5 others. Clin Sci (Lond), 2013. Cited by 218 papers, by iCite.
Cite this record
ConductScience Library. Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. Papers, record 22876972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22876972
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain | Major topic |
| Brain Injuries | Major topic |
| Culture Media, Conditioned | Major topic |
| Mesenchymal Stem Cells | Major topic |
| Animals | |
| Apoptosis | |
| Avoidance Learning | |
| Bone Marrow Cells | |
| Cell Hypoxia | |
| Cells, Cultured | |
| Enzyme-Linked Immunosorbent Assay | |
| Hepatocyte Growth Factor | |
| Humans | |
| Male | |
| Motor Activity | |
| Neurogenesis | |
| Neurons | |
| Rats | |
| Rats, Sprague-Dawley | |
| Vascular Endothelial Growth Factor A |
Source PubMed
Cited by152
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 218 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42645220 | Human Mesenchymal Stromal Cells Attenuate Hyperoxia-Induced Cellular Impairment of Immature Oligodendrocyte and Neurons. | Cells | 2026 | https://conductscience.org/library/papers/42645220 | PubMed |
| 42577309 | Effects of hypoxia on the biological characteristics of urine-derived stem cells. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42577309 | PubMed |
| 41913036 | Quieting the Storm: Hypoxia as a Strategy to Boost UC-MSC Therapies for Hypoxic-Ischemic Brain Lesions in Neonatal Rats. | Stem Cell Rev Rep | 2026 | https://conductscience.org/library/papers/41913036 | PubMed |
| 41514404 | Effect of bone marrow stem cell conditioned medium on amiodarone-induced submandibular salivary gland and kidney damage in male albino rats. | BMC Oral Health | 2026 | https://conductscience.org/library/papers/41514404 | PubMed |
| 41210257 | Functional impacts of lactylation in Hypoxia‒primed mesenchymal stromal cells. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/41210257 | PubMed |
| 41096767 | Osteoporosis-Improving Effects of Extracellular Vesicles from Human Amniotic Membrane Stem Cells in Ovariectomized Rats. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41096767 | PubMed |
| 40990865 | Hydrogen Sulfide-Preconditioned Mesenchymal Stem Cells Attenuate Ferroptosis in Corneal Alkali Burn via the AMPK/Nrf2/HO-1 Pathway in an IL-10-Dependent Manner. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/40990865 | PubMed |
| 40933041 | Stem cell and CRISPR/Cas9 gene editing technology in Alzheimer's disease therapy: from basic research to clinical innovation. | Front Genome Ed | 2025 | https://conductscience.org/library/papers/40933041 | PubMed |
| 40589994 | Therapeutic role of mesenchymal stem cells in neurogenesis for management of neurological disorders: a scientometric study to an in-depth review. | Front Neurol | 2025 | https://conductscience.org/library/papers/40589994 | PubMed |
| 40352183 | Umbilical cord mesenchymal stem cell-derived secretome as a potential treatment for systemic lupus erythematosus: A double-blind randomized controlled trial. | Narra J | 2025 | https://conductscience.org/library/papers/40352183 | PubMed |
| 40158179 | Autoimmunity and clinical pathology amelioration in SLE by dexamethasone primed mesenchymal stem cell derived conditioned media. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/40158179 | PubMed |
| 39765683 | Unlocking the Therapeutic Potential of Adipose-Derived Stem Cell Secretome in Oral and Maxillofacial Medicine: A Composition-Based Perspective. | Biology (Basel) | 2024 | https://conductscience.org/library/papers/39765683 | PubMed |
| 39305405 | Therapeutic Applications of Engineered Mesenchymal Stromal Cells for Enhanced Angiogenesis in Cardiac and Cerebral Ischemia. | Stem Cell Rev Rep | 2024 | https://conductscience.org/library/papers/39305405 | PubMed |
| 39171894 | Biosponge-Encased Placental Stem Cells for Volumetric Muscle Loss Repair. | Adv Wound Care (New Rochelle) | 2025 | https://conductscience.org/library/papers/39171894 | PubMed |
| 39085403 | Neuroserpin normalization by mesenchymal stem cell therapy after encephalopathy of prematurity in neonatal rats. | Pediatr Res | 2025 | https://conductscience.org/library/papers/39085403 | PubMed |
| 38939990 | Neuro-regeneration or Repair: Cell Therapy of Neurological Disorders as A Way Forward. | Curr Neuropharmacol | 2024 | https://conductscience.org/library/papers/38939990 | PubMed |
| 38786067 | Preconditioning of MSCs for Acute Neurological Conditions: From Cellular to Functional Impact-A Systematic Review. | Cells | 2024 | https://conductscience.org/library/papers/38786067 | PubMed |
| 38615278 | Comparison of different sources of mesenchymal stem cells: focus on inflammatory bowel disease. | Inflammopharmacology | 2024 | https://conductscience.org/library/papers/38615278 | PubMed |
| 38523616 | Mapping knowledge of the stem cell in traumatic brain injury: a bibliometric and visualized analysis. | Front Neurol | 2024 | https://conductscience.org/library/papers/38523616 | PubMed |
| 38523514 | Potential Druggability of Mesenchymal Stem/Stromal Cell-derived Exosomes. | Curr Stem Cell Res Ther | 2024 | https://conductscience.org/library/papers/38523514 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HGF | 3082 | PubTator's text mining | https://conductscience.org/library/genes/3082 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22876972
GET https://conductscience.org/api/papers/v1/22876972/cited_by?page=2